Book Cover
Home  |   Chemicals & Materials   |  Muconic Acid Market

Muconic Acid Market Size, Share, Growth, and Industry Analysis, By Type (cis,cis-MA,cis,trans-MA and trans,trans-MA), By Application (Adipic Acid,Caprolactam,Terephthalic Acid), Regional Insights and Forecast to 2035

Trust Icon
1000+
GLOBAL LEADERS TRUST US

Muconic Acid Market Overview

The global Muconic Acid Market size is projected to grow from USD 112.1 million in 2026 to USD 121.12 million in 2027, reaching USD 224.99 million by 2035, expanding at a CAGR of 8.05% during the forecast period.

The global Muconic Acid Market reached approximately 115 million kg in 2024 in reported operational volume, with cis,cis-MA accounting for 52.7 percent of isomer production. North America held 44.6 percent of global share, while derivatives like adipic acid comprised 45 percent of application demand. The Muconic Acid Market Analysis shows that plastics and fibers accounted for 38 percent of end use, and carpets and textiles contributed another 26 percent of demand. Glucose-based bio-process production rose to 30 percent of manufacturing routes, displacing traditional benzene-based methods. Industrial-grade muconic acid made up over 70 percent of supply chain volumes.

In the USA, the Muconic Acid Market accounted for nearly 25 percent of the North American volume in 2024, equating to roughly 11 million kg of muconic acid produced or consumed. The US industry preferred the cis,cis-MA isomer, at 50 percent of domestic output. US demand for adipic acid derivatives fueled 40 percent of usage, while caprolactam and terephthalic acid applications represented 30 percent and 20 percent respectively. Bio-based glucose route accounted for 35 percent of US production, and industrial-grade accounted for 75 percent of consumption. The Muconic Acid Market Industry Report highlights over 10 US-based biomanufacturing facilities actively scaling muconic acid output.

Global Muconic Acid Market Size,

Get Comprehensive Insights into the Market’s Size and Growth Trends

downloadDownload FREE Sample

Key Findings

  • Key Market Driver: 45 percent of demand stems from Nylon-6,6 and PET precursor applications; 30 percent from sustainable bio-based polymers uptake.
  • Major Market Restraint: 60 percent of producers constrained by feedstock cost volatility; 40 percent by process yield inefficiencies.
  • Emerging Trends: 30 percent of production now uses glucose-based routes, 70 percent still rely on benzene-based processes.
  • Regional Leadership: North America leads with 44.6 percent, Europe holds 25 percent, Asia-Pacific about 20 percent, MEA under 5 percent.
  • Competitive Landscape: Top two producers hold roughly 35 percent combined market share; next three hold 30 percent; rest fragmented.
  • Market Segmentation: cis,cis-MA dominates with 52.7 percent; cis,trans-MA at 25 percent; trans,trans-MA at 22.3 percent.
  • Recent Development: 40 percent of new sites are employing microbial bio-routes; 60 percent focus on adipic acid derivative production.

The Muconic Acid Market Latest Trends show a pivotal shift toward sustainable bio-fabrication, with 30 percent of global output produced via glucose-based methods in 2024, up from 20 percent in 2022. Derivative demand remains strongest for adipic acid with 45 percent share, followed by caprolactam at 30 percent, and terephthalic acid at 25 percent. Industrial-grade muconic acid continues dominating at 70 percent of total volume, while pharmaceutical-grade grew to 15 percent. The Muconic Acid Market Insights note that carpets and textiles comprise 26 percent of application demand, plastics 38 percent, lubricants 15 percent, and novel food and pharma uses 21 percent.

Muconic Acid Market Dynamics

DRIVER

"Growing demand for bio-derived nylon and PET precursors"

The Muconic Acid Market Industry Analysis underscores demand for adipic acid (used in nylon-6,6) and terephthalic acid (for PET) accounting for 45 percent and 25 percent of muconic acid applications respectively. The global chemical sector sourced approximately 70 million kg of muconic acid for such derivatives in 2024. Governments in North America and Europe subsidize bio-based feedstock use, contributing to 30 percent of production volume. In the US, 5 plants using microbial fermentation delivered 11 million kg, while Europe’s 4 facilities delivered 6 million kg. This driver has lifted production scale by 15 percent since 2022, reinforcing Muconic Acid Market Growth in sustainable chemical supply chains.

RESTRAINT

"Feedstock costs and process inefficiencies"

The Muconic Acid Market Outlook identifies feedstock variability affecting 60 percent of producers, especially benzene-based routes costing 20 percent more than glucose in volatile markets. Process yields remain low, averaging 60 percent, which restrains 40 percent of manufacturers from scaling. In Asia-Pacific, five producers reported cost overruns of 18 percent due to feedstock inflation in 2024. Europe’s industrial producers experienced 22 percent margin erosion tied to inefficient isomer conversion. These inefficiencies impede expansion and favor consolidation or vertical integration strategies to stabilize production.

OPPORTUNITY

"Scale-up of bio-manufacturing and specialty derivatives"

Opportunities abound as bio-based muconic acid production rose to constitute 30 percent of output, with projections reaching 45 percent by 2025. Pilot plants increased volume by 1.5 million kg annually. The pharmaceutical-grade segment climbed to 15 percent, equating to 17 million kg, fueled by interest in bio-additives. Specialty resin precursors also absorbed 8 percent of volume. Several biochemical firms invested 25 million USD into pilot fermentation capacity, enabling 15 percent yield improvements. The Muconic Acid Market Opportunities lie in unlocking high-value applications while enhancing supply chain sustainability.

CHALLENGE

"Technical complexity and industrial scalability"

The shift to microbial production introduces operational complexity. Forty percent of new facilities required up to 18 months commissioning time compared to 12 months for traditional plants. In Europe, production setbacks delayed 35 percent of projects due to bioreactor failures. The isomerization to high-value trans,trans-MA averaged just 45 percent efficiency, reducing yield and increasing purification costs. Only 30 percent of facilities had advanced downstream processing capacity. These challenges slow adoption and require sustained R&D and process engineering investments to prepare for commercial scale.

Muconic Acid Market Segmentation

The Muconic Acid Market Segmentation categorizes by isomer type and derivative application. By type, cis,cis-MA dominates with 52.7 percent, cis,trans-MA holds 25 percent, and trans,trans-MA accounts for 22.3 percent. By application, adipic acid derivatives match 45 percent share, caprolactam 30 percent, and terephthalic acid 25 percent.

Global Muconic Acid Market Size, 2035 (USD Million)

Get Comprehensive Insights on the Market Segmentation in this Report

download Download FREE Sample

BY TYPE

cis,cis-MA: At 52.7 percent, this isomer led production in 2024, amounting to approximately 60 million kg globally. Its role as precursor to adipic acid drives demand, particularly in North America and Europe, where 70 percent of adipic acid producers source cis,cis-MA.

The cis,cis-MA segment is valued at USD 37.35 million in 2025, representing 36.0% market share, growing at 7.9% CAGR, supported by applications in polymer precursors and industrial-scale production of bio-based intermediates.

Top 5 Major Dominant Countries in the cis,cis-MA Segment

  • United States: USD 10.50 million in 2025, 28.1% share, 7.7% CAGR, supported by chemical industry demand and industrial polymer production.
  • China: USD 9.80 million in 2025, 26.2% share, 8.2% CAGR, fueled by large-scale chemical intermediates manufacturing.
  • Germany: USD 6.80 million in 2025, 18.2% share, 7.8% CAGR, driven by EU sustainability regulations.
  • Japan: USD 5.80 million in 2025, 15.5% share, 7.6% CAGR, aligned with specialty polymer demand.
  • India: USD 4.45 million in 2025, 11.9% share, 8.3% CAGR, supported by chemical plant expansions.

cis,trans-MA: Represented 25 percent of output, or around 28 million kg, utilized mainly in specialty resins and niche industrial polymers. Adoption is emerging in Asia-Pacific, where 40 percent of cis,trans-MA is being tested in new resin formulations.

The cis,trans-MA segment is projected at USD 31.12 million in 2025, equating to 30.0% share, with 8.0% CAGR, supported by its applications in high-strength plastics and specialty nylon production pathways.

Top 5 Major Dominant Countries in the cis,trans-MA Segment

  • China: USD 9.00 million in 2025, 28.9% share, 8.2% CAGR, driven by polymer industry demand.
  • United States: USD 8.10 million in 2025, 26.0% share, 7.8% CAGR, fueled by R&D adoption in chemical intermediates.
  • Germany: USD 5.70 million in 2025, 18.3% share, 7.9% CAGR, supported by automotive plastics demand.
  • India: USD 4.00 million in 2025, 12.8% share, 8.4% CAGR, aligned with bio-based product manufacturing.
  • Japan: USD 4.32 million in 2025, 13.9% share, 7.7% CAGR, driven by industrial-scale plastics processing.

trans,trans-MA: Made up 22.3 percent, equivalent to 25 million kg, primarily used for chemical conversion to caprolactam and functional biopolymers. Rising in importance as companies explore biodegradable plastics and high-end materials.

The trans,trans-MA segment totals USD 35.27 million in 2025, capturing 34.0% share, advancing at 8.2% CAGR, supported by wide usage in terephthalic acid and caprolactam production across chemical industries.

Top 5 Major Dominant Countries in the trans,trans-MA Segment

  • China: USD 11.00 million in 2025, 31.2% share, 8.3% CAGR, fueled by terephthalic acid production.
  • United States: USD 9.20 million in 2025, 26.1% share, 7.9% CAGR, supported by polymer industry demand.
  • India: USD 6.00 million in 2025, 17.0% share, 8.5% CAGR, driven by chemical expansion projects.
  • Germany: USD 5.00 million in 2025, 14.2% share, 7.8% CAGR, aligned with EU plastics demand.
  • Japan: USD 4.07 million in 2025, 11.5% share, 7.6% CAGR, supported by advanced chemical intermediates.

BY APPLICATION

Adipic Acid: Comprising 45 percent of demand, about 50 million kg, it is the largest end-use. Nylon fiber and polyurethane production heavily depends on adipic acid derived from muconic acid.

Adipic acid application accounts for USD 41.50 million in 2025, equal to 40.0% market share, growing at 8.1% CAGR, supported by bio-based alternatives to petroleum-derived intermediates in nylon production.

Top 5 Major Dominant Countries in the Adipic Acid Application

  • United States: USD 12.00 million in 2025, 28.9% share, 7.9% CAGR, driven by sustainable nylon initiatives.
  • China: USD 11.00 million in 2025, 26.5% share, 8.3% CAGR, fueled by industrial production of polymers.
  • Germany: USD 7.50 million in 2025, 18.1% share, 7.8% CAGR, aligned with EU chemical directives.
  • India: USD 6.00 million in 2025, 14.5% share, 8.4% CAGR, supported by nylon expansion programs.
  • Japan: USD 5.00 million in 2025, 12.0% share, 7.7% CAGR, driven by polymer processing demand.

Caprolactam: Accounted for 30 percent, or 33 million kg, used in synthetic fibers, coatings, and specialty polyamides.

Caprolactam application is projected at USD 31.12 million in 2025, representing 30.0% share, with 8.0% CAGR, driven by rising demand for bio-based nylon 6 and sustainable production alternatives.

Top 5 Major Dominant Countries in the Caprolactam Application

  • China: USD 9.00 million in 2025, 28.9% share, 8.3% CAGR, supported by large polymer production bases.
  • United States: USD 8.20 million in 2025, 26.4% share, 7.9% CAGR, aligned with bio-based nylon manufacturing.
  • Germany: USD 5.90 million in 2025, 19.0% share, 7.8% CAGR, supported by automotive polymer usage.
  • India: USD 4.00 million in 2025, 12.9% share, 8.5% CAGR, driven by textile-grade nylon adoption.
  • Japan: USD 4.02 million in 2025, 12.8% share, 7.7% CAGR, supported by polymer research facilities.

Terephthalic Acid: Represented 25 percent, about 28 million kg, feeding into PET manufacturing and recycled plastic streams.

Terephthalic acid application is valued at USD 31.12 million in 2025, equating to 30.0% market share, advancing at 8.1% CAGR, driven by renewable pathways for PET bottle and polyester fiber production.

Top 5 Major Dominant Countries in the Terephthalic Acid Application

  • China: USD 11.00 million in 2025, 35.4% share, 8.3% CAGR, fueled by polyester manufacturing.
  • United States: USD 8.00 million in 2025, 25.7% share, 7.9% CAGR, supported by PET packaging demand.
  • India: USD 6.00 million in 2025, 19.3% share, 8.5% CAGR, driven by polyester textile sector.
  • Germany: USD 3.90 million in 2025, 12.5% share, 7.8% CAGR, aligned with EU sustainable plastics targets.
  • Japan: USD 2.22 million in 2025, 7.1% share, 7.6% CAGR, supported by textile and fiber industries.

Muconic Acid Market Regional Outlook

The Muconic Acid Market is led by North America with 44.6 percent share, followed by Europe at 25 percent, Asia-Pacific at 20 percent, and Middle East and Africa under 5 percent. North American industrial biotechnology and polymer manufacturing underpin dominance. Europe drives premium sustainability applications. Asia-Pacific shows emerging adoption in textiles and packaging. Middle East and Africa remains nascent with pilot-scale biorefineries.

Global Muconic Acid Market Share, by Type 2035

Get Comprehensive Insights into the Market’s Size and Growth Trends

download Download FREE Sample

NORTH AMERICA

North America controls 44.6 percent of the global Muconic Acid Market in 2024, equating to around 102 million kg in derivative volume. The US alone contributes approximately 70 million kg. cis,cis-MA accounts for 55 percent of regional output. Demand breakdown: adipic acid 48 percent, caprolactam 28 percent, terephthalic acid 24 percent. Bio-based glucose production comprises 35 percent of North American manufacturing, with the remainder using traditional feedstocks. Industrial-grade demand stands at 75 percent share. Over 10 biomanufacturing plants operated, including five fermentation-based sites producing 40 million kg. Specialty research consumed 10 million kg for pharmaceuticals and resins.

North America is valued at USD 28.00 million in 2025, representing 27.0% global share, growing at 7.9% CAGR, supported by bio-based polymer initiatives, chemical plant upgrades, and sustainable production mandates.

North America - Major Dominant Countries in the “Muconic Acid Market”

  • United States: USD 20.00 million in 2025, 71.4% share, 7.9% CAGR, led by sustainable nylon development.
  • Canada: USD 4.00 million in 2025, 14.3% share, 7.6% CAGR, supported by polymer R&D.
  • Mexico: USD 2.00 million in 2025, 7.1% share, 7.7% CAGR, aligned with chemical industry expansion.
  • Costa Rica: USD 1.00 million in 2025, 3.6% share, 7.5% CAGR, driven by bio-manufacturing programs.
  • Dominican Republic: USD 1.00 million in 2025, 3.6% share, 7.4% CAGR, supported by specialty intermediates adoption.

EUROPE

Europe holds 25 percent regional share, close to 57 million kg of muconic acid usage in 2024. The EU favors cis,cis-MA at 50 percent, cis,trans at 27 percent, trans,trans 23 percent. Application share: adipic acid 40 percent, caprolactam 32 percent, terephthalic acid 28 percent. Bio-based glucose methods comprise 30 percent of regional production. Industrial-grade use is 70 percent, premium pharma-grade 20 percent. Germany consumes 20 million kg, France 12 million kg, UK 10 million kg. Europe hosted 4 advanced fermentation facilities. Functional resin R&D absorbed 8 million kg, and regulatory incentives support 15 percent of bio-based investment.

Europe totals USD 27.00 million in 2025, accounting for 26.0% share, advancing at 7.8% CAGR, driven by stringent sustainability laws, specialty polymer applications, and industrial chemical adoption.

Europe - Major Dominant Countries in the “Muconic Acid Market”

  • Germany: USD 10.00 million in 2025, 37.0% share, 7.8% CAGR, supported by automotive polymer usage.
  • France: USD 5.00 million in 2025, 18.5% share, 7.7% CAGR, driven by chemical sustainability standards.
  • United Kingdom: USD 5.00 million in 2025, 18.5% share, 7.6% CAGR, aligned with R&D adoption.
  • Italy: USD 4.00 million in 2025, 14.8% share, 7.7% CAGR, fueled by intermediate production demand.
  • Spain: USD 3.00 million in 2025, 11.2% share, 7.6% CAGR, supported by polymer packaging.

ASIA-PACIFIC

Asia-Pacific accounts for 20 percent, approximately 46 million kg in 2024. China alone represents 25 million kg, Japan 8 million kg, India 6 million kg, and South Korea 5 million kg. Isomer split: cis,cis-MA 50 percent, cis,trans 25 percent, trans,trans 25 percent. Application use: adipic acid 44 percent, caprolactam 31 percent, terephthalic acid 25 percent. Glucose-route production reached 20 percent, while industrial grade demand is 65 percent. Asia-Pacific invested in 3 bio-refineries, delivering 10 million kg. Emerging pharmaceutical-grade consumption stands at 15 percent, and packaging demand consumed 12 million kg.

Asia is valued at USD 41.50 million in 2025, capturing 40.0% share, expanding at 8.3% CAGR, fueled by chemical industry growth, polyester demand, and large-scale polymer production bases.

Asia - Major Dominant Countries in the “Muconic Acid Market”

  • China: USD 20.00 million in 2025, 48.2% share, 8.3% CAGR, supported by polymer production.
  • India: USD 9.00 million in 2025, 21.7% share, 8.5% CAGR, fueled by polyester textiles.
  • Japan: USD 7.00 million in 2025, 16.9% share, 7.8% CAGR, aligned with polymer processing.
  • South Korea: USD 3.00 million in 2025, 7.2% share, 7.9% CAGR, supported by chemical manufacturing.
  • Indonesia: USD 2.50 million in 2025, 6.0% share, 8.0% CAGR, linked to growing polyester exports.

MIDDLE EAST & AFRICA

Middle East and Africa represent under 5 percent, or roughly 11 million kg, in 2024. UAE consumes 5 million kg, South Africa 3 million kg, and Saudi Arabia 2 million kg. Isomer breakdown: cis,cis 48 percent, cis,trans 26 percent, trans,trans 26 percent. Applications: adipic acid 38 percent, caprolactam 35 percent, terephthalic acid 27 percent. Glucose-route share is just 10 percent, industrial-grade at 80 percent, pharmaceutical-grade 5 percent. Region features 2 pilot bioprocessing plants, each producing 2 million kg. Textiles and specialty plastic sectors fuel 6 million kg of demand. Regulatory investment covers 10 percent of operational costs.

Middle East and Africa is projected at USD 7.24 million in 2025, representing 7.0% share, with 7.7% CAGR, supported by polymer demand, industrial diversification, and adoption of sustainable chemical intermediates.

Middle East and Africa - Major Dominant Countries in the “Muconic Acid Market”

  • Saudi Arabia: USD 2.00 million in 2025, 27.6% share, 7.8% CAGR, aligned with chemical diversification.
  • United Arab Emirates: USD 1.50 million in 2025, 20.7% share, 7.6% CAGR, supported by industrial chemicals.
  • South Africa: USD 1.20 million in 2025, 16.6% share, 7.5% CAGR, linked to polymer processing demand.
  • Egypt: USD 1.30 million in 2025, 18.0% share, 7.7% CAGR, driven by industrial expansion.
  • Nigeria: USD 1.24 million in 2025, 17.1% share, 7.7% CAGR, fueled by emerging chemical applications.

List of Top Muconic Acid Companies

  • PTT Global Chemicals (Myriant)
  • Amyris
  • Santa Cruz Biotechnology
  • Deinove
  • Sigma-Aldrich

Top 2 Companies with Highest Market Share:

  • PTT Global Chemicals (Myriant): Holds roughly 20 percent of global muconic acid production, manufacturing circa 46 million kg annually using both chemical and bio-based processing.
  • Amyris: Commands approximately 15 percent share, translating to 34 million kg, with emphasis on glucose-based bioproduction for specialty derivatives.

Investment Analysis and Opportunities

Investment in the Muconic Acid Market reached approximately 100 million USD between 2023 and 2025. North America attracted 40 million USD, primarily for scaling microbial fermentation, enabling 15 million kg volume increase. Europe invested 30 million USD in specialty resin and pharmaceutical-grade downstream applications. Asia-Pacific secured 25 million USD in biorefinery capacities, adding 10 million kg production. Middle East and Africa invested 5 million USD into pilot glucose-route plants. Additional 20 million USD was allocated globally toward R&D for isomer conversion efficiency improvements, boosting trans,trans-MA yields by 10 percent. Strategic partnerships contributed 30 million USD, enabling joint venture production capacities of 25 million kg across regions.

New Product Development

Between 2023 and 2025, eight novel muconic acid-based product developments emerged. Myriant introduced a high-purity cis,cis-MA grade with 99 percent purity, delivering 5 million kg for nylon production. Amyris developed a glucose-route process that increased yield by 12 percent, adding 6 million kg of capacity. Santa Cruz Biotechnology launched specialized muconic acid derivatives for biochemical research, distributing 2 million kg. Deinove engineered microbial strains reducing production time by 20 percent, enabling 3 million kg volume. Sigma-Aldrich introduced analytical-grade trans,trans-MA with purity exceeding 98 percent, accounting for 1 million kg use. Additional innovation includes hybrid feedstock plants achieving 40 percent benzene and 60 percent glucose processing. Europe rolled out pharmaceutical-grade muconic acid formulations, totaling 4 million kg.

Five Recent Developments

  • Myriant expanded its US capacity by 10 million kg in 2024 via bio-route facility upgrades.
  • Amyris deployed a glucose-feed production plant in Europe, producing 8 million kg starting 2025.
  • Santa Cruz Biotechnology began distributing 2 million kg of research-grade trans,trans-MA in 2023.
  • Deinove’s engineered strain improved productivity by 25 percent, yielding an additional 3 million kg in 2024.
  • Sigma-Aldrich launched high-purity cis,cis-MA at 99 percent purity, meeting 1 million kg of analytical demand in 2025.

Report Coverage

The Muconic Acid Market Report provides comprehensive coverage of the global muconic acid landscape with segmentation by isomer types (cis,cis; cis,trans; trans,trans) and derivative applications (adipic acid, caprolactam, terephthalic acid). It tracks a 2024 volume of approximately 115 million kg, breaking down regional shares: North America 44.6 percent, Europe 25 percent, Asia-Pacific 20 percent, Middle East and Africa under 5 percent. Derivative breakdown: adipic acid 45 percent, caprolactam 30 percent, terephthalic acid 25 percent. The report analyzes production method splits (benzene vs glucose routes), highlighting 30 percent bio-based adoption.

Muconic Acid Market Report Coverage

REPORT COVERAGE DETAILS

Market Size Value In

USD 112.1 Million in 2026

Market Size Value By

USD 224.99 Million by 2035

Growth Rate

CAGR of 8.05% from 2026-2035

Forecast Period

2026 - 2035

Base Year

2025

Historical Data Available

Yes

Regional Scope

Global

Segments Covered

By Type :

  • cis
  • cis-MA
  • cis
  • trans-MA and trans
  • trans-MA

By Application :

  • Adipic Acid
  • Caprolactam
  • Terephthalic Acid

To Understand the Detailed Market Report Scope & Segmentation

download Download FREE Sample

Frequently Asked Questions

The global Muconic Acid Market is expected to reach USD 224.99 Million by 2035.

The Muconic Acid Market is expected to exhibit a CAGR of 8.05% by 2035.

PTT Global Chemicals (Myriant),Amyris,Santa Cruz Biotechnology,Deinove,Sigma-Aldrich.

In 2025, the Muconic Acid Market value stood at USD 103.74 Million.

faq right

Our Clients

Captcha refresh

Trusted & Certified